 |
|
New research suggests that recognising early impairments may make Alzheimer's a treatable disease
March 16, 1999Alzheimer's Disease need no longer be a death sentence but will become more treatable, if detected in its early stages. Evidence on brain scans, in conjunction with performance on psychological test showing mild cognitive impairments (MCI) like slight memory loss, pinpoints more people at risk of developing Alzheimer's Disease. A study at SCP will use new brain imaging techniques to assess the impact of drug treatment given when mild cognitive impairments appear, for delaying the progression of Alzheimer's disease.
Alzheimer's disease, a form of dementia, affects up to 25 million people worldwide. In the UK, alone about £5 billion is needed every year to care for people with the disease. There are currently two treatments available that delay the progression of symptoms by increasing transmission of the chemical acetylcholine in the brain. These drugs - cognition enhancers - have most effect when used in the early stages of Alzheimer's and may be useful before symptoms of Alzheimer's are apparent.
Performance on neuropsychological tests can indicate mild cognitive impairments - memory loss, difficulty learning new things - but these are also signs of normal ageing. Visual evidence of atrophy can be detected on brain images and can support a diagnosis of Alzheimer's Disease.
Functional magnetic resonance imaging (fMRI ) - a new imaging technique - is already successfully used to map the effects of antipsychotic drugs on the brain in schizophrenia. In Alzheimer's disease, fMRI may prove useful in mapping the drug effects of the cognitive enhancers and in detecting early changes in the brain that may predict dementia.
Institute of Psychiatry
Functional magnetic resonance imaging (fMRI ) - a new imaging technique - is already successfully used to map the effects of antipsychotic drugs on the brain in schizophrenia. In Alzheimer's disease, fMRI may prove useful in mapping the drug effects of the cognitive enhancers and in detecting early changes in the brain that may predict dementia.
Institute of Psychiatry
Alzheimer Disease Current Events and Alzheimer Disease News RSSDelirium in hospitalized adults: Situation critical, no relief available
Every year as many as seven million adults in the United States experience delirium during hospitalization.
New data demonstrate potential for early detection of Alzheimer's disease
Data published in the June issue of the Journal of Alzheimer's Disease demonstrated that minimally-invasive biospectroscopy was able to identify changes in oxidative stress (OS) levels in blood plasma, which may prove to be a useful biomarker in the early detection of Alzheimer's disease.
Another McGill/JGH breakthrough opens door to early Alzheimer's diagnosis
A new diagnostic technique which may greatly simplify the detection of Alzheimer's disease has been discovered by researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital (JGH).
Measuring brain atrophy in patients with mild cognitive impairment
Scientists at the University of California, San Diego School of Medicine have shown that a fully automated procedure called Volumetric MRI - which measures the "memory centers" of the brain and compares them to expected size - is effective in predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease.
Commonly used medications may produce cognitive impairment in older adults
Many drugs commonly prescribed to older adults for a variety of common medical conditions including allergies, hypertension, asthma, and cardiovascular disease appear to negatively affect the aging brain causing immediate but possibly reversible cognitive impairment, including delirium, in older adults.
Commonly used ulcer drugs may offer treatment potential in Alzheimer's disease
In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug.
New test for mysterious metabolic diseases developed at Stanford/Packard
Scientists at Stanford University School of Medicine have devised a much-needed way to monitor and find treatments for a mysterious and devastating group of metabolic diseases that arise from mutations in cells' fuel-burning mechanism.
Recalibrating 'fight or flight'
A Canadian/U.S. research team has reported a novel approach to stimulating recovery from chronic stress disorders. Details of the therapeutic model, which exploits the natural dynamics of the body's "fight or flight" system, are published January 23 in the open-access journal PLoS Computational Biology
Vitamin B does not slow cognitive decline in Alzheimer's
A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease.
Protecting patient privacy the new fashioned way
Protecting patient privacy has been recognized as the duty of health-care providers for about as long as doctors have seen patients. In 1996 that duty became a legal obligation when Congress passed the Health Insurance Portability and Accountability Act.
More Alzheimer Disease Current Events and Alzheimer Disease News Articles
 |
A Caregiver's Guide to Alzheimer's Disease: 300 Tips for Making Life Easier by Patricia R. Callone (Editor) Written for patients, their families, and caregivers, the practical information here will help readers understand what is physically happening to the brain so they can empower their own special skills and talents throughout the disease process. The book is divided into three sections that correspond to the progression of Alzheimer’s, and the unique challenges encountered at each stage. *Section A: The four stages of Alzheimer's with hundreds of practical tips for coping at each level *Section B: Q&A for caregivers, including legal and financial issues, medication, helping children understand, handling the holidays and more. *Section C: Resources and websites. This is an essential book for all those who want to focus on the capabilities that... |
 |
Learning to Speak Alzheimer's: A Groundbreaking Approach for Everyone Dealing with the Disease by Joanne Koenig Coste (Author), Robert Butler (Foreword) More than four million Americans suffer from Alzheimer’s, and as many as twenty million have close relatives or friends with the disease. Revolutionizing the way we perceive and live with Alzheimer’s, Joanne Koenig Coste offers a practical approach to the emotional well-being of both patients and caregivers that emphasizes relating to patients in their own reality. Her accessible and comprehensive method, which she calls habilitation, works to enhance communication between carepartners and patients and has proven successful with thousands of people living with dementia. Learning to Speak Alzheimer’s also offers hundreds of practical tips, including how to · cope with the diagnosis and adjust to the disease’s progression · help the patient talk about the illness · face the... |
 |
Alzheimer's Disease: Facing the Facts Starring: n/a Directed By: n/a Studio: Wgbh Wholesale Release Date: 03/17/2009 Run time: 56 minutes |
 |
My Journey into Alzheimer's Disease by Robert Davis (Author) A book of encouragement of how one man of faith faced the oncoming darkness of Alzheimer's disease. In a powerful story of courage and faith, Davis shows how God gives strength and grace. |
 |
The Alzheimer's Action Plan: What You Need to Know--and What You Can Do--about Memory Problems, from Prevention to Early Intervention and Care by P. Murali Doraiswamy M.D. (Author), Lisa P. Gwyther M.S.W. (Author), Tina Adler (Author) What would you do if your mother was having memory problems? |
|
Journal of Alzheimers Disease by Ios Press | |
 |
Alzheimer's from the Inside Out by Richard Taylor (Author) Receiving a diagnosis of Alzheimer’s disease profoundly alters lives and creates endless uncertainty about the future. How does a person cope with such a life-changing discovery? What are the hopes and fears of someone living with this disease? How does he want to be treated? How does he feel as the disease alters his brain, his relationships, and ultimately himself?
Richard Taylor provides illuminating responses to these and many other questions in this collection of provocative essays. Diagnosed with Alzheimer’s disease at age 61, the former psychologist courageously shares an account of his slow transformation and deterioration and the growing division between his world and the world of others.
With poignant clarity, candor, and even occasional humor, more than... |
![Trouble in Mind: Alzheimer's Disease [VHS]](http://ecx.images-amazon.com/images/I/41VJXB4JBHL._SL160_.jpg) |
Trouble in Mind: Alzheimer's Disease [VHS] Starring: Kate Jackson |
 |
FlameEz-Memory, 60 Capsules/Bottle by FlameEz Memory loss is caused by a condition in which cells of the brain are damaged or lost. Dementia and Alzheimer's disease are the common disorders that cause memory loss. Studies have shown that neuron damage begins long before an individual experiences any symptoms and the symptoms are only recognized when many cells have died and the brains can no longer function properly. Unlike many cells in the rest of the body, neurons are not readily regenerated. For this reason, memory loss is a progressive condition that only gets worse, there is no coming back from it. Advanced science has shown critical role of inflammation in Alzheimer's and neurodegenerative diseases. When the brain is injured or infected, cells in the brain called microglia produce inflammatory cytokines. Normally, this... |
 |
Caring for the Caregiver -- A Guide to Living with Alzheimer's Disease 171 pages |
| © 2009 BrightSurf.com |